首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1561903

美國消費者健康市場

Consumer Health in the US

出版日期: 2024年09月17日 | 出版商:

Euromonitor International | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2024年美國消費者健康市場各類別將呈現溫和環境。通膨壓力有所緩解，價格漲幅有所放緩，而咳嗽藥、感冒藥和過敏藥 (CCA) 等季節性類別藥品在 2022 年達到高峰後繼續保持穩定。隨著品牌產品成本的正常化和供應鏈效率的提高，自有品牌產品的價格也有所下降。

本報告檢視了美國消費者健康市場並提供了市場概況，包括2019年至2023年的最新零售資料、市場機會和未來展望。

由於消費者持續受到通貨膨脹、經濟不確定性和價格持續上漲的影響，預計 2024 年皮膚科產品的表現將好壞參半
新的政策變化和增加的服務供應預計將影響驅蟲/蝨子（頭部和身體）治療的效果
消費者安全和皮膚健康的首要任務推動皮膚科產品的創新

前景和機遇

消費者對天然和非藥物解決方案的興趣可能會在預測期內減緩皮膚科藥物的成長
數位參與可能是提高品牌知名度、建立社區和教育消費者的一個有前途的途徑
競爭環境正在加劇，美容/個人護理和處方箋產品的壓力預計將增加。

分類資料

美國的 NRT 戒菸援助

主要資料結果

2024年發展

補丁格式持續表現停滯不前
海倫的國際撤資標誌著國內局勢的不確定軌跡
未來將會出現更多D2C品牌

前景和機遇

尼古丁戒斷藥物：潛在的類別顛覆者？
ZYN 尼古丁袋的不確定監管狀況可能有利於傳統 NRT 解決方案
美國年輕人使用電子煙和尼古丁袋的情況增加

類別指標

分類資料

美國安眠藥

主要資料結果

2024年發展

隨著傳統產品失去主導地位，助眠劑的價值成長持續下降
天然睡眠支持成分受益於「Sleepy Girl無酒精調飲」等數位趨勢
DTC 和知名品牌正在透過推出新產品來探索睡眠補充品的創新

前景和機遇

老字型大小企業如何在面臨威脅的領域進行創新
零售電子商務預計將在未來的助眠劑和睡眠相關類別中繼續發揮關鍵作用
兒科睡眠產品或因擔憂而失去褪黑素定位

分類資料

美國眼部護理

主要資料結果

2024年發展

過敏季節的加劇增加了對過敏眼部護理產品的需求並刺激了創新
乾眼症仍然處於眼部護理產品進步的前沿
眼藥水回想凸顯眼健康教育的重要性

前景和機遇

氣候條件惡化為眼醫療產業帶來機遇
永續配方是優質化的關鍵
化妝品定位可望實現標準眼部護理

分類資料

美國創傷護理

主要資料結果

2024年發展

成熟度持續限制創傷護理的成長
Kenview 處於創傷護理領域的前沿，提供各種高品質產品。
零售電子商務成為創傷護理的熱門通路

前景和機遇

儘管目前受到限制，但產品創新是價值成長的關鍵
危險的「永久化學物質」可能會阻礙傷口護理的成長前景
成熟度和人口下降將限制數量成長，但永續性證書將是一個關鍵賣點

分類資料

美國維生素

主要資料結果

2024年發展

維生素價值維持穩定成長
推動成長的獨特行銷策略
自有品牌受惠於價格實惠與價值

前景和機遇

維生素與機能性食品和飲料的競爭正在加劇
增加針對特定健康問題的個人化方法
創新是確保有價值銷售持續成長的關鍵

分類資料

美國食品補充劑

主要資料結果

2024年發展

膳食食品的價值正在穩步成長，富含蛋白質的營養食品也受益於健康意識的提高。
健康產業併購增加
亞馬遜採用新的補充品指南

前景和機遇

營養食品預計將保持穩定成長。針對特定消費群組推出
促進女性健康和內在美麗的產品不斷增加
多功能性和個人化獲得更多動力

分類資料

美國的體重管理與健康

主要資料結果

2024年發展

體重管理和健康的價值正在直線下降
向青少年銷售減肥藥和增肌補充品的法律限制
改變對減重方法的看法

前景和機遇

消費者在服用 GLP-1 藥物後重新進入該類別的可能性
對於對體重管理感興趣的消費者來說，與飲食和運動相關的生活方式改變仍然是首要任務
GLP-1 支援產品可協助您管理體重並改善您的健康

分類資料

美國運動營養

主要資料結果

2024年發展

隨著人們對健康和健身的關注不斷增加，運動營養又迎來了強勁的一年
創新在吸引更廣泛的受眾方面發揮關鍵作用
透過零售電商和全通路策略加強運動營養滲透

前景和機遇

運動營養的個人化勢頭強勁
健康概念變得模糊，產業之間的競爭加劇。
永續運動營養獲得進一步發展動力

分類資料

美國草本/傳統產品

主要資料結果

2024年發展

草本/傳統產品今年將持續成長
創新是草本/傳統產品持續成長的關鍵
適應原和蘑菇作為大腦和認知健康產品的崛起

前景和機遇

草藥/傳統食品補充劑作為減重方法的混合效果
持續關注女性健康可能會強調月經健康支持並推廣管理月經疼痛的綜合解決方案
對功效和安全性的擔憂可能會導致進一步的監管，表明草藥/傳統產品的成長可能會放緩

分類資料

美國兒科消費者健康

主要資料結果

2024年發展

兒科止痛藥、咳嗽感冒藥和抗過敏藥的需求預計將從 2022 年的高峰繼續下降
將成分創新擴展到兒科睡眠產品和褪黑激素產品之外
監測營養趨勢和服用均衡補充品的重要性日益增加

前景和機遇

小兒止痛公司有機會透過形式和成分創新擾亂市場
推出新產品以擴大基本客群，並專注於天然/草藥趨勢
兒科維生素和營養食品前景光明

分類資料

簡介目錄

Product Code: CHUS

In 2024, the consumer health landscape in the US is marked by a moderated environment across various categories. Inflationary pressures have eased, leading to slightly slower price increases, while seasonal categories such as cough, cold, and allergy remedies (CCAs) continue to stabilise after the peaks observed in 2022. Private label offerings have also moderated, as the cost of branded products has normalised and supply chain efficiencies improved.

Euromonitor International's Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Consumer Health market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

List Of Contents And Tables

EXECUTIVE SUMMARY

Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DISCLAIMER

DEFINITIONS

SOURCES

Summary 1 Research Sources

ANALGESICS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Analgesics overall to see a softer value performance in 2024
A new class of pain relief prescription medicine could bring change to analgesics
Continued momentum in topical analgesics/anaesthetic fuelled by new product launches

PROSPECTS AND OPPORTUNITIES

Aspirin and naproxen to witness continued declines over the forecast period
Emphasis on menstrual health could lead to combination menstrual pain management products
Paediatric-oriented players could disrupt analgesics through format and ingredient formulations

CATEGORY DATA

Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Cough, cold and allergy (hay fever) remedies continues its return to normality
Private label momentum slows amidst easing price pressures
Haleon's Robitussin recalled for microbial contamination

PROSPECTS AND OPPORTUNITIES

Climate change to influence stable consumer uptake for cough, cold, and allergy remedies
FDA's phenylephrine ruling could disrupt major players in cough and cold remedies
Pharyngeal preparations to experience cannibalisation from medicated confectionery

CATEGORY DATA

Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029

DIGESTIVE REMEDIES IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Digestive remedies continues to benefit from post-pandemic health changes and wellness-oriented product developments
Digestive remedies direct-to-consumer disruptor brand Wonderbelly enters CVS
Big brands and direct-to-consumer brands compete with product launches

PROSPECTS AND OPPORTUNITIES

Laxatives well-positioned for US demographic shifts
PPIs set to see significantly reduced consumer intake over the forecast period due to side-effects and substitutes
Digestive support products positioned for women's health could witness heightened mergers and acquisitions activity

CATEGORY DATA

Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029

DERMATOLOGICALS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Mixed performance expected in dermatologicals in 2024, as consumers continue struggling with inflation, economic uncertainty, and ongoing price increases
New policy changes and rise in service-based offerings expected to impact the performance of antiparasitics/lice (head and body) treatments
Top consumer priorities of safety and skin health spur innovation in dermatologicals

PROSPECTS AND OPPORTUNITIES

Consumer interest in natural and non-medicated solutions could moderate the growth of dermatologicals over the forecast period
Digital engagement could provide a promising avenue to improve brand perception, build communities, and educate consumers
The competitive environment is set to intensify, with rising pressure expected from beauty and personal care, as well as prescription-based offerings

CATEGORY DATA

Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029

NRT SMOKING CESSATION AIDS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Patch format continues to witness a stagnant performance
Haleon's international divestments hint at uncertain trajectory for the domestic landscape
More direct-to-consumer brands on the horizon

PROSPECTS AND OPPORTUNITIES

Nicotine cessation medication: Potential category disruptor?
Uncertain regulatory landscape for ZYN nicotine pouches could benefit traditional NRT solutions
Vaping and usage of nicotine pouches increasing amongst younger generations in the US

CATEGORY INDICATORS

Table 37 Number of Smokers by Gender 2019-2024

CATEGORY DATA

Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029

SLEEP AIDS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Value growth in sleep aids continues to fall as traditional products lose their edge
Natural sleep support ingredients see benefits from digital trends, such as the "sleepy girl mocktail"
DTC and legacy brands look to innovate through sleep supplementation in new product launches

PROSPECTS AND OPPORTUNITIES

How legacy players will look to innovate in a category under threat
Retail e-commerce expected to continue to play a major role in the future of sleep aids and sleep adjacent categories
Paediatric sleep products could move away from melatonin positioning due to concerns

CATEGORY DATA

Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029

EYE CARE IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

The heightened allergy season is driving demand for allergy eye care products and sparking innovation
Dry eye conditions remain at the forefront of advances in eye care offerings
Recalls of eye drops highlight the significance of eye health education

PROSPECTS AND OPPORTUNITIES

Worsening climate conditions present an opportunity for eye care players
Sustainable formulations will be a crucial factor in terms of premiumisation
Beauty positioning shows promise for standard eye care

CATEGORY DATA

Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029

WOUND CARE IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Maturity continues to limit growth in wound care
Kenvue remains at the forefront of wound care, offering a diverse range of high-quality products
Retail e-commerce emerges as a popular distribution channel for wound care

PROSPECTS AND OPPORTUNITIES

Product innovation, while currently constrained, will be key to drive value growth
Dangerous "forever chemicals" may hinder the growth prospects for wound care
Maturity and declining population to limit volume growth; however, sustainability credentials set to become an important selling point

CATEGORY DATA

Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029

VITAMINS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Vitamins maintains a steady value growth performance
Unique marketing tactics to stimulate growth
Private label benefits from affordability and value

PROSPECTS AND OPPORTUNITIES

Vitamins set to face increasing rivalry from functional food and drinks
Rise in personalised approach to focus on targeted health concerns
Innovation is key to ensuring continuous growth in value sales

CATEGORY DATA

Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029

DIETARY SUPPLEMENTS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Dietary supplements experiences steady value growth; protein-rich dietary supplements benefit from heightened health awareness
The rise of mergers and acquisitions in the wellness industry
New supplement guidelines adopted by Amazon

PROSPECTS AND OPPORTUNITIES

Dietary supplements set to maintain solid growth; launches will be targeted towards specific consumer groups
Products for women's health and beauty from within on the rise
Multifunctionality and personalisation set to gain further momentum

CATEGORY DATA

Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029

WEIGHT MANAGEMENT AND WELLBEING IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Weight management and wellbeing sees a steeper value decline
Legislative restrictions on sale of diet pills and muscle-building supplements to teens
Changing perception of methods of weight loss

PROSPECTS AND OPPORTUNITIES

Consumers' potential re-entry to the category after taking GLP-1 drugs
Lifestyle shifts in terms of diet and exercise remain top-of-mind for weight management consumers
GLP-1 support products on the rise in weight management and wellbeing

CATEGORY DATA

Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029

SPORTS NUTRITION IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Another strong year for sports nutrition, owing to an increased focus on health and fitness
Innovation plays a crucial role in reaching a broader audience
Retail e-commerce and omnichannel strategy strengthen penetration of sports nutrition

PROSPECTS AND OPPORTUNITIES

Personalisation set to gain momentum in sports nutrition
Cross-industry competition increases in response to the blurring wellness concept
Sustainable sports nutrition set to gain further momentum

CATEGORY DATA

Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029

HERBAL/TRADITIONAL PRODUCTS IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Herbal/traditional products experiences another year of growth
Innovation is key to maintaining growth for herbal/traditional products
Rise of adaptogens and mushrooms as brain and cognitive health products

PROSPECTS AND OPPORTUNITIES

Mixed performance of herbal/traditional dietary supplements as a method for weight loss
Continued interest in women's health could highlight menstrual health support and drive integrated solutions for managing menstrual pain
Concerns about efficacy and safety could lead to further regulation, hinting at the potential slower growth of herbal/traditional products

CATEGORY DATA

Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029

PAEDIATRIC CONSUMER HEALTH IN THE US

KEY DATA FINDINGS

2024 DEVELOPMENTS

Paediatric analgesics and cough, cold and allergy remedies set to continue to decline from their 2022 peak
Paediatric sleep offerings to expand ingredient innovation beyond melatonin products
Increased emphasis on monitoring nutritional trends and balanced supplement intake

PROSPECTS AND OPPORTUNITIES

Opportunities for players in paediatric analgesics to disrupt the market through format and ingredient innovation
Focus on natural/herbal trends, and new launches to widen the customer base
Positive outlook for paediatric vitamins and dietary supplements

CATEGORY DATA

Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029

02-2729-4219

+886-2-2729-4219